CytoLab Ltd.

CytoLab Ltd. is a Biotechnology company dedicated to providing life science research with the highest quality cytokine products. Using state-of-the-art facilities, proprietary technology and devoted personnel, CytoLab has been successful in developing an extensive line of recombinant cytokines growth factors, chemokines and neurotrophins as well as a complementary line of monoclonal and Polyclonal antibodies.
In collaboration with its New-Jersey based affiliated company PeproTech, the two companies have currently over 300 products characterized by utmost purity, high specific activity and are marketed worldwide.
CytoLab has the capacity and technology for bulk production to address bio-pharmaceutical markets and is seeking potential customers for bulk cytokine and growth factors or customers who whish to acquire the technology for production of bio-pharmaceuticals.

Activity:

- Contract Manufacturing
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics
- Proteins
- Technology

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Cancer
- Diabetes
- Hematology
- Infectious Diseases
- Neurology
- Obesity
- Oncology

Markets Covered

a. HeadQuarter: Israel

b. Continent(s) active: North America , Asia , Australia/New-Zealand , Near/Middle East , Africa , Europe

c. Countries active: USA, Australia, China, Korea, Israel, Taiwan, India, Russia, Poland, Singapore, New Zealand, South Africa

Corporate data:

Number of Employees: -

Turnover:

Amount:	Year:	Currency:
-	2001	US Dollar

Year founded: 1997